Natera Shares Outstanding 2014-2023 | NTRA
Natera shares outstanding history from 2014 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Natera shares outstanding for the quarter ending December 31, 2023 were 0.115B, a 16.86% increase year-over-year.
- Natera 2023 shares outstanding were 0.115B, a 16.86% increase from 2022.
- Natera 2022 shares outstanding were 0.098B, a 8.67% increase from 2021.
- Natera 2021 shares outstanding were 0.091B, a 11.78% increase from 2020.
| Natera Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 115 |
| 2022 | 98 |
| 2021 | 91 |
| 2020 | 81 |
| 2019 | 70 |
| 2018 | 58 |
| 2017 | 54 |
| 2016 | 52 |
| 2015 | 26 |
| 2014 | 5 |
| 2013 | 4 |
| Natera Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 115 |
| 2023-09-30 | 115 |
| 2023-06-30 | 114 |
| 2023-03-31 | 112 |
| 2022-12-31 | 98 |
| 2022-09-30 | 97 |
| 2022-06-30 | 97 |
| 2022-03-31 | 96 |
| 2021-12-31 | 91 |
| 2021-09-30 | 93 |
| 2021-06-30 | 88 |
| 2021-03-31 | 87 |
| 2020-12-31 | 81 |
| 2020-09-30 | 81 |
| 2020-06-30 | 79 |
| 2020-03-31 | 78 |
| 2019-12-31 | 70 |
| 2019-09-30 | 70 |
| 2019-06-30 | 68 |
| 2019-03-31 | 63 |
| 2018-12-31 | 58 |
| 2018-09-30 | 61 |
| 2018-06-30 | 55 |
| 2018-03-31 | 54 |
| 2017-12-31 | 54 |
| 2017-09-30 | 53 |
| 2017-06-30 | 53 |
| 2017-03-31 | 53 |
| 2016-12-31 | 52 |
| 2016-09-30 | 52 |
| 2016-06-30 | 51 |
| 2016-03-31 | 50 |
| 2015-12-31 | 26 |
| 2015-09-30 | 45 |
| 2015-06-30 | 5 |
| 2015-03-31 | 5 |
| 2014-12-31 | |
| 2014-09-30 | 37 |
| 2014-06-30 | 5 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.298B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.512B | 15.50 |
| Cencora (COR) | United States | $47.702B | 19.04 |
| ICON (ICLR) | Ireland | $23.778B | 23.45 |
| DiDi Global (DIDIY) | China | $21.472B | 0.00 |
| Avantor (AVTR) | United States | $16.347B | 22.52 |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| CochLear (CHEOY) | $13.392B | 0.00 | |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.462B | 0.00 |
| Revvity (RVTY) | United States | $12.459B | 21.69 |
| Charles River Laboratories (CRL) | United States | $11.682B | 21.29 |
| Medpace Holdings (MEDP) | United States | $11.526B | 41.89 |
| Solventum (SOLV) | United States | $10.730B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.940B | 51.85 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.595B | 34.21 |
| Organon (OGN) | United States | $4.555B | 4.41 |
| PACS (PACS) | United States | $3.551B | 0.00 |
| Progyny (PGNY) | United States | $3.143B | 52.74 |
| Sotera Health (SHC) | United States | $3.100B | 15.21 |
| Surgery Partners (SGRY) | United States | $3.017B | 28.03 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.643B | 133.80 |
| Premier (PINC) | United States | $2.538B | 9.29 |
| Agilon Health (AGL) | United States | $2.244B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.198B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.158B | 6.98 |
| BrightSpring Health Services (BTSG) | United States | $1.799B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.301B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.301B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.983B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.611B | 4.04 |
| InnovAge Holding (INNV) | United States | $0.537B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.519B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.59 |
| Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
| CareDx (CDNA) | United States | $0.430B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| LifeMD (LFMD) | United States | $0.392B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.388B | 0.00 |
| DocGo (DCGO) | United States | $0.372B | 59.50 |
| Sera Prognostics (SERA) | United States | $0.316B | 0.00 |
| ModivCare (MODV) | United States | $0.302B | 4.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.263B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
| Sharecare (SHCR) | United States | $0.235B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.115B | 38.67 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |